Abstract: backgROund: Isotretinoin is a synthetic analog of vitamin A. Recent studies support a role for retinoic acid in the recovery of olfactory function following injury in mice. Objective: This study aimed at determining the effect of isotretinoin on olfactory function in patients who have acne and are otherwise healthy. MethOds: Forty-five patients (aged 25-40 years) with acne were included in the study. All patients underwent a rhinological examination. Olfactory function was assessed by the Sniffin' Sticks Test. The test was assessed at baseline and in the third month of isotretinoin treatment. Results: Isotretinoin improved the performance of patients in the olfactory test. The SST score increased from 8.7±1.09 to 9.5±1.19 (p<0.001), prevalence of hyposmia decreased from 40% to 24% and normosmia increased from 60% to 75% (p=0.059). The percentage of patients whose olfactory function was categorized as "good" increased from 6% to 21.3%. This increase was statistically significant (p<0.05). study liMitatiOns: Absence of a control group is one of the limitations of this study. Also, we did not evaluate patients with smell test after stopping isotretinoin treatment. cOnclusiOn: We examined the effect of systemic isotretinoin on olfactory function. It can be concluded from the present investigation that isotretinoin therapy improves the sense of smell.
INTRODUCTION
Olfaction plays important roles in the daily lives of patients, and a disturbance in olfaction is mostly experienced as a severe decrease in quality of life. 1 Approximately 20% of the general population complains about an impaired sense of smell, and 5% of these people are anosmic. 2, 3 An olfactory disturbance can result in the inability to detect the odors of spoiled food, smoke, and leaking gas. Additionally, anosmic patients cannot detect the aroma and flavor of foods, thus problems in quality of life are essentially in the areas of safety and eating. [4] [5] [6] [7] Isotretinoin (13-cis retinoic acid) is a synthetic analog of vitamin A. It is indicated for systemic treatment of severe acne (such as nodular or conglobate acne) in patients resistant to standard courses of standard therapy with systemic antibacterials and topical therapy. Even though systemic retinoids are very effective medications, they have some adverse events. The most common adverse events are mucocutaneous (dryness, cheilitis, palmoplantar exfoliation, rash, and dermatitis), gastrointestinal (inflammatory bowel disease), and ocular problems (conjunctivitis and dry eye). 8 Retinoic acids (RA), including isotretinoin, can influence cellular growth, morphogenesis, differentiation, apoptosis and malignant cell growth. They can inhibit tumor promotion, exert immuno-modulatory actions and alter cellular cohesiveness. 9 Many studies about the different effects of RA have been reported. Some of these reports relate to the effects of RA on olfactory function. The results support a role for RA in the recovery of olfactory function following injury in mice. 10, 11 There has not been any previous clinical study about the effect of RA on olfactory function in humans treated with isotretinoin. Therefore, we aimed at determining the effect of isotretinoin on olfactory function in patients who have acne and are otherwise healthy.
METHOD
This study was a prospective study that was approved by each odor, the patients were asked to find the right answer from a questionnaire including four options. All answers were recorded to obtain a score for both nostrils. All patients were asked which odor is most pleasant or unpleasant. The patients were classified as normosmia (10-12 scores), hyposmia (7-9 scores) and anosmia (0-6 scores) according to the right answers. In addition, patients were asked to rate their olfaction subjectively into one of three categories (good, fair, or poor). The Sniffin' Sticks Test was performed twice before starting the isotretinoin therapy and particularly in the third month of treatment.
All statistical analyses were performed using the IBM SPSS Prevalence of hyposmia and normosmia was 40% and 60%, respectively, before treatment and 24% and 75%, respectively, after 
DISCUSSION
Retinoic acids, which are members of the steroid/thyroid hormone superfamily, can influence cellular growth, morphogenesis, differentiation, and apoptosis and malignant cell growth. They can also inhibit tumor promotion, exert immuno-modulatory actions, and alter cellular cohesiveness. 9 In recent years, it has been shown that signaling via RA regulates olfactory neural stem cells throughout life. 13 RA regulation of immune function may also assist cell maintenance, clearance or turnover in the olfactory pathway, especially in the OE, which is directly exposed to many toxins and irritants. The most unpleasant odors for the STS scores baseline B a n a n a B a n a n a B a n a n a C in n a m o n C o ff e e C in n a m o n C in n a m o n O r a n g e C o ff e e C o ff e e P e p p e r m in t P in e a p p le O r a n g e O r a n g e P e p p e r m in t P e p p e r m in t P in e a p p le P in e a p p le R o s e R o s e R o s e B a n a n a C lo v e s C lo v e s C lo v e s C lo v e s C lo v e s B a n a n a C o ff e e F is h F is h F is h F is h F is h C o ff e e O r a n g e L e a th The non-neural OE cells express RARα (RA receptors), as do macrophages that invade or proliferate in the OE following nerve transaction. 11 In one study, the authors showed that RA treatment increased the number of RARα-expressing macrophages in mice, and they found that this increase correlated with more rapid recovery of olfactory function. 10, 11 There are many animal studies on the effects of RA on olfactory function in the literature, but there is not yet any clinical study using isotretinoin.
In our study, we evaluated the patients before treatment and again in the third month of treatment. Results from recent studies were used to plan the second time point for evaluation. It has been shown that olfactory neurons regenerate every 20-60 days, and this regeneration is completed in 3-6 months. 22, 23 We therefore chose to evaluate the patients in the third month of treatment.
We found significant differences (p<0.001) in the SST scores between the before and after isotretinoin treatment values. Increase in olfactory function between all groups was observed when patients subjectively rated their olfaction as good, fair and poor, and it was statistically significant between groups.
Although there appeared to be an improvement regarding the prevalence of hyposmia and normosmia between the before and after isotretinoin treatment values, the apparent improvement was not statistically significant. Our results showed that isotretinoin has an enhancing effect on olfactory function.
It is well known that isotretinoin has some mucocutaneous adverse events that are associated with decreasing sebum production, which leads to changes in the epidermis that, in turn, lead to xerosis and mucosal dryness (cheilitis and dry nose). 8 It is well known that nasal mucosa dryness leads to decongestion. We thought that the increased function observed in our study related to increased airflow in nasal passages due to decongestion. Yee and colleagues investigated the effect of all-trans retinoic acid (ATRA) treatment effects on mice that had undergone left olfactory nerve transection. 11 They showed that ATRA plays a role in recovery of the olfactory epithelium after injury. Our study is a clinical study. Our results suggest an effect of retinoic acid on olfactory function. We showed the effects of isotretinoin with the Sniffin' Stick Test.
Jeden et al. used vitamin A at a dose of 10,000 IU per day for three months to treat patients who had postinfectious and posttraumatic smell disorders. 24 They suggested that there was no positive effect of vitamin A therapy on olfactory function. In their study, all participants had smell disorders due to infections or trauma. In our study, our patients did not have any diagnosed smell disorders. Perhaps vitamin A given during the recovery period is not enough for patients who have postinfectious or posttraumatic smell disorders.
And perhaps isotretinoin is a better choice than vitamin A.
Roydhouse reported two patients with a loss of smell who were treated with etretinate, an oral aromatic retinoid acid. Both patients experienced an improvement in their sense of smell. 25 In our study, our patients used isotretinoin for acne. Etretinate is very slowly released over a prolonged period of time. A number of drug toxicity cases have appeared 4 months to 4 years after the cessation of treatment. Pregnancies are contraindicated for at least 3 years after discontinuation of etretinate treatment; this period of contraindication is only 2 months for isotretinoin. 26, 27 In this regard, isotretinoin seems to offer advantages over etretinate.
Study limitations
The absence of a control group is one of the limitations of this study. Also, we did not evaluate patients with smell test after stopping the isotretinoin treatment.
CONCLUSION
In this study, we examined the effect of systemic isotretinoin on olfactory function. It can be concluded from the present investigation that isotretinoin therapy improves the sense of smell. Further investigations with a large number of patients are required to assess the effect of systemic isotretinoin on olfactory function. q
